AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARTRYA LTD

3.900

+0.2205.98%

Volume:399.81K

Turnover:1.50M

Market Cap:616.53M

PE:-22.64

High:3.900

Open:3.700

Low:3.560

Close:3.680

52wk High:5.240

52wk Low:0.570

Shares:158.08M

Float Shares:76.77M

Volume Ratio:0.73

T/O Rate:0.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.172

EPS(LYR):-0.178

ROE:-37.89%

ROA:-23.75%

PB:6.90

PE(LYR):-21.95

Loading ...

Overview Company News Filings

Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call

Simply Wall St.

Can Anticipation Around Artrya (ASX:AYA)'s Earnings Call Reveal Shifts in Investor Confidence?

Simply Wall St.

Buy Hold Sell: The hottest ASX small caps right now (and 2 on the rise)

ASX Growth Companies With High Insider Ownership To Watch In November 2025

Simply Wall St.

High Growth Tech Stocks in Australia for November 2025

Simply Wall St.

Artrya Says US Heart Center Agrees to Participate in Coronary Artery Disease Patients Study; Shares Fall 6%

MT Newswires Live

Becoming a substantial holder from WAM/WAA/WMI/WAX

Artrya Ltd-Completion of Placement and Cleansing Notice

THOMSON REUTERS

Why investors are betting big on AI-powered health care

Artrya Secures First US Revenue in September Quarter, Shares Fall 10%

MT Newswires Live

3 hot sectors, a handful of stock ideas, and what could come next

Artrya Completes Q-Submission Meeting with US FDA; Shares Reach All-Time High

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","market":"AU","secType":"STK","nameCN":"ARTRYA LTD","latestPrice":3.9,"timestamp":1775801196751,"preClose":3.68,"halted":0,"volume":399812,"delay":0,"changeRate":0.059782608695652106,"nameEN":"ARTRYA LTD","floatShares":76766493,"shares":158084000,"eps":-0.172236,"marketStatus":"Pre CSPA","change":0.22,"latestTime":"04-10 16:08:07 AEST","open":3.7,"high":3.9,"low":3.56,"amount":1497771,"amplitude":0.092391,"askPrice":3.51,"askSize":1216,"bidPrice":4.1,"bidSize":2024,"shortable":3,"etf":0,"ttmEps":-0.172236,"tradingStatus":3,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1776038400000},"marketStatusCode":13,"adr":0,"exchange":"ASX","adjPreClose":3.68,"openAndCloseTimeList":[[1775779200000,1775800800000]],"volumeRatio":0.727721,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AYA.AU","preClose":3.68,"auctionPrice":4,"auctionVolume":35602,"auctionTime":1775801196751,"referencePrice":3.9,"referenceTime":1775801196751,"auction":3,"marketStatus":"盘后竞价","timestamp":1775801196751}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","floatShares":76766493,"roa":"-23.75%","roe":"-37.89%","lyrEps":-0.177705,"volumeRatio":0.727721,"shares":158084000,"dividePrice":0,"high":3.9,"amplitude":0.092391,"preClose":3.68,"low":3.56,"week52Low":0.57,"pbRate":"6.90","psRate":"21259.57","week52High":5.24,"institutionHeld":0,"latestPrice":3.9,"committee":0.249383,"eps":-0.172236,"divideRate":0,"volume":399812,"delay":0,"ttmEps":-0.172236,"open":3.7,"prevYearClose":4.71,"prevWeekClose":3.13,"prevMonthClose":3.27,"prevQuarterClose":3.27,"fiveDayClose":3.31,"twentyDayClose":3.5,"sixtyDayClose":4.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582903468","title":"Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2582903468","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582903468?lang=en_us&edition=fundamental","pubTime":"2025-11-09 18:23","pubTimestamp":1762683799,"startTime":"0","endTime":"0","summary":"Artrya (ASX:AYA) is on investors’ radar this week, as anticipation grows ahead of its Q1 2026 earnings call scheduled for October 29, 2025. Market watchers are waiting to see how recent trends translate into results.\nSee our latest analysis for Artrya.\nMomentum has been building for Artrya, with a 27.6% share price return over the past month and a remarkable 445.2% year-to-date. Over the last twelve months, total shareholder return stands at an impressive 576.0%, highlighting the surge in...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA.AU","AYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581856842","title":"Can Anticipation Around Artrya (ASX:AYA)'s Earnings Call Reveal Shifts in Investor Confidence?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581856842","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581856842?lang=en_us&edition=fundamental","pubTime":"2025-11-08 08:39","pubTimestamp":1762562366,"startTime":"0","endTime":"0","summary":"Artrya Limited has announced its upcoming Q1 2026 earnings call, scheduled for October 29, 2025, signaling a key moment for stakeholders awaiting developments from the company.\nThis earnings call has captured increased user attention, reflecting heightened anticipation in the absence of other major company announcements in recent weeks.\nWe'll explore how anticipation around Artrya's upcoming earnings call shapes the company's investment narrative and investor expectations.\nExplore 27 top...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/can-anticipation-around-artrya-asxayas-earnings-call-reveal","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/can-anticipation-around-artrya-asxayas-earnings-call-reveal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA","AYA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581011155","title":"Buy Hold Sell: The hottest ASX small caps right now (and 2 on the rise)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011155","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581011155?lang=en_us&edition=fundamental","pubTime":"2025-11-07 04:00","pubTimestamp":1762459215,"startTime":"0","endTime":"0","summary":"Unless you've been living under a rock, chances are you're aware of the resurgence in small-cap stocks. The ASX Small Ordinaries is up 19% year-to-date, versus just 7% for the ASX 100.But it's not just a rotation away from growth-starved large caps that is seeing smalls catch a bid. The recent reporting season showed that many small caps are in rude health, with strong balance sheets and improved earnings backed by margin expansion, built on a bedrock of innovation and competitive advantage.That's the good news but, of course, not all small caps are created equal. Investors need to be highly selective when considering less mature businesses.Against that backdrop, Livewire's Chris Conway sat down withJames Nguyen from Tyndall and Shaun Weick from Wilson Asset Management to understand their most important factors when assessing companies and run the ruler over three of the hottest ASX small caps.For good measure, they each share a small-cap name they believe is on the rise.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-the-hottest-asx-small-caps-right-now-and-2-on-the-rise","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-the-hottest-asx-small-caps-right-now-and-2-on-the-rise","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7017","AYA.AU","BK7089","NWL.AU","MQG.AU","BUY.AU","BK7046","BK7142","COG.AU","BK7094","BK7062","SDV.AU","BUY","BK7054","HOLD","GDG.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581104672","title":"ASX Growth Companies With High Insider Ownership To Watch In November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581104672","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581104672?lang=en_us&edition=fundamental","pubTime":"2025-11-07 03:08","pubTimestamp":1762456100,"startTime":"0","endTime":"0","summary":"Amidst the current market volatility and geopolitical uncertainties, Australia's stock market has been experiencing fluctuations, with inflation concerns and sector-specific performances shaping investor sentiment. In this environment, identifying growth companies with high insider ownership can be an attractive strategy as it often indicates strong confidence from those closest to the business, potentially aligning well with investors seeking stability and potential long-term value.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-companies-with-high-insider-ownership-to-watch-in-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-dvp/develop-global-shares/news/asx-growth-companies-with-high-insider-ownership-to-watch-in-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7016","A4N.AU","TTT.AU","BK7094","DVP.AU","XKO.AU","BB1.AU","BK7093","BK7036","IR1.AU","BK7084","BK7017","POL.AU","AV1.AU","WZR.AU","BK7116","ELS.AU","BK7104","EIQ.AU","BK7095","XAO.AU","XJO.AU","NWF.AU","AYA.AU","3DP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581046771","title":"High Growth Tech Stocks in Australia for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581046771","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581046771?lang=en_us&edition=fundamental","pubTime":"2025-11-07 03:06","pubTimestamp":1762455965,"startTime":"0","endTime":"0","summary":"The Australian market has been navigating a period of uncertainty, with key indices fluctuating due to geopolitical events and rising inflation, while sectors like materials have shown resilience amidst these challenges. In this environment, identifying high growth tech stocks requires focusing on companies that demonstrate robust adaptability and innovation to thrive despite broader market volatility.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/high-growth-tech-stocks-in-australia-for-november-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cuv/clinuvel-pharmaceuticals-shares/news/high-growth-tech-stocks-in-australia-for-november-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CUV.AU","XAO.AU","BK7508","BK7067","BK7094","XJO.AU","AYA.AU","XKO.AU","IFM.AU","BK7503","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581104791","title":"Artrya Says US Heart Center Agrees to Participate in Coronary Artery Disease Patients Study; Shares Fall 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581104791","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581104791?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:28","pubTimestamp":1762302517,"startTime":"0","endTime":"0","summary":"Artrya  said that Mass General Brigham has agreed to participate as a collaborator in the company's SAPPHIRE study, to assess the role of the company's platform, Salix, in detecting coronary artery disease earlier and more effectively, according to a Wednesday filing with the Australian bourse.The company expects to launch the study in early 2026, the filing said.Shares of the company fell past 6% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRD.SI","AYA.AU","BK7094","BK6045","BK6520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580200704","title":"Becoming a substantial holder from WAM/WAA/WMI/WAX","url":"https://stock-news.laohu8.com/highlight/detail?id=2580200704","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580200704?lang=en_us&edition=fundamental","pubTime":"2025-11-04 16:05","pubTimestamp":1762243517,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251104:nASX3gy9XW","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nASXcgdlNl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU","WMI.AU","WAM.AU","WAX.AU","WAA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579109246","title":"Artrya Ltd-Completion of Placement and Cleansing Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579109246?lang=en_us&edition=fundamental","pubTime":"2025-10-31 06:37","pubTimestamp":1761863825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE2CZRKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579431719","title":"Why investors are betting big on AI-powered health care","url":"https://stock-news.laohu8.com/highlight/detail?id=2579431719","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579431719?lang=en_us&edition=fundamental","pubTime":"2025-10-29 10:43","pubTimestamp":1761705819,"startTime":"0","endTime":"0","summary":"Note: This interview was recorded on Sunday, 19 October 2025.Artificial intelligence is transforming healthcare diagnostics - from how images are read to how hospitals make decisions. In the latest episode of Market Mixers, hosts Ally Selby and I explore how AI is reshaping the sector and what investors should watch as innovation comes for diagnostics.The first wave of AI in diagnostic healthcare focused on imaging. Companies like Heartflow pioneered cardiac CT analysis, turning standard scans into 3D models that quantify plaque and blood flow. This image-based AI offered structured pixels, clear economics, and measurable value for clinicians, so they could better decide who really needs invasive procedures.The second wave targeted workflow. Instead of simply spotting disease, new models optimised efficiency, cutting analyst time from over an hour to less than half that. Competitors such as Artrya aim to go even further, pushing toward real-time, point-of-care automation.Meanwhile, Art","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/why-investors-are-betting-big-on-ai-powered-health-care","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/why-investors-are-betting-big-on-ai-powered-health-care","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK4543","AI","BK4588","BK4023","BK4587","BK4585","BK7094","BK4551","BK4528","AYA.AU","HTFL","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578966206","title":"Artrya Secures First US Revenue in September Quarter, Shares Fall 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578966206","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578966206?lang=en_us&edition=fundamental","pubTime":"2025-10-27 13:11","pubTimestamp":1761541871,"startTime":"0","endTime":"0","summary":"Artrya  said it secured its first US commercial customer, Tanner Health, in the September quarter, and this generated its first US revenue, according to a Monday Australian bourse filing.The firm revised its US go-to-market strategy, accelerating initiatives to build commercial operations and to seek further customers and revenue. It named a senior US-based customer success director and began hiring US-based integration specialists, clinical field specialists, and customer support personnel.Its shares fell 10% in recent trading on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575416222","title":"3 hot sectors, a handful of stock ideas, and what could come next","url":"https://stock-news.laohu8.com/highlight/detail?id=2575416222","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575416222?lang=en_us&edition=fundamental","pubTime":"2025-10-15 04:00","pubTimestamp":1760472030,"startTime":"0","endTime":"0","summary":"There have been three dominant sector winners in the last 12 months – AI, gold and defence. These should hardly come as a surprise.There are queues down Martin Place to purchase bullion. Geopolitical risks have heightened and, on the back of a US push, most economies are stepping up their defence spending. And AI hardly needs an explanation as it continues its game-changing growth.Conversely, it’s been a hard year for healthcare, which has been hit by the US tariff on pharmaceuticals, along with vaccine scepticism, and pricing pressures.There’s also been plenty of good economic news out of the US to bolster markets – inflation appears steady, jobs numbers have held up for the most part, and the rate-cutting cycle is still underway to support consumer spending. The story has been mostly similar in Australia – even with a surprise jump in the last inflation print.Only last week, the S&P500 reached 6,764.66 while the S&P/ASX 200 hit an all-time high of 9054.50 back in August. It wasn’t th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/3-hot-sectors-a-handful-of-stock-ideas-and-what-could-come-next","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/3-hot-sectors-a-handful-of-stock-ideas-and-what-could-come-next","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["PPE.AU","BBN.AU","SKS.AU","IE00B19Z9Z06.USD","BK4196","APE.AU","BK4551","DUG.AU","AMI.AU","BK4539","AYA.AU","LU2087625088.SGD","AI","BK7016","IE00B894F039.SGD","IE00BZ9MQY76.HKD","EOL.AU","LU0097036916.USD","BK4543","IE00B19Z9P08.USD","DRO.AU","BK4023","DXB.AU","TUA.AU","NUTX","BK7067","BK7021","XJO.AU","BK4608","BK7023","BK4185","LU0353189680.USD","MLX.AU","BK7094","UNI.AU","APP","FIX","SXE.AU","XAO.AU","BK7057","BK7115","BK7501","BK4167","BK7506","CRWV","LRV.AU","BK4588","BK7143","BK4129","XKO.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2574119984","title":"Artrya Completes Q-Submission Meeting with US FDA; Shares Reach All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2574119984","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574119984?lang=en_us&edition=fundamental","pubTime":"2025-10-10 08:54","pubTimestamp":1760057664,"startTime":"0","endTime":"0","summary":"Artrya  completed a Q-Submission meeting with the US Food and Drug Administration as part of advancing regulatory clearance for the Salix Coronary Flow  module, according to a Friday filing with the Australian bourse.The FDA provided guidance to secure 510 clearance, which will help the company refine its SCF 510 application, the filing said.The final 510 pre-market application is anticipated to be submitted to the FDA by the end of the year, per the filing.Shares rose more than 2% in morning trade on Friday and earlier reached their all-time high.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":32,"code":"91000000","status":"200"}]}}